Randomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter-associated complications in adults living with long-term catheters

ISRCTN ISRCTN17116445
DOI https://doi.org/10.1186/ISRCTN17116445
IRAS number 259559
Secondary identifying numbers CPMS 41284, IRAS 259559
Submission date
04/11/2019
Registration date
06/11/2019
Last edited
08/04/2025
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Urinary catheters are soft tubes put into the bladder to drain and then collect urine. In the UK, an average of 1 in 1000 people use long-term indwelling catheters. People using these catheters can experience complications, like blockages (where the urine does not drain into the catheter bag properly), urinary infections, pain, and a type of incontinence called catheter bypass. These complications can affect a person’s quality of life. They may also mean more emergency visits with nurses and GPs. Research shows that people consider blockage to be one of the most troubling aspects of using catheters over a long period. In current standard catheter care, catheter blockages are dealt with by either changing the catheter more often and/or using catheter washout liquids to washout the catheter. Some people are advised to do a catheter washout every week to try to reduce blockages. Others are not. The difference is because at present, there is no clear evidence to show whether doing regular washouts helps avoid blockages. People doing washouts also use different solutions. One is a weak salty (saline) solution, and the other is a citric mix, more like weak lemon juice. Both solutions are used in the NHS but it is not known which works best. The aim of this study is to find out the best way to reduce the number of blockages that can happen in people who have long-term indwelling catheters to find out if washing out the catheter every week using catheter washout liquids reduces catheter blockages and other problems like urinary incontinence or urinary tract infections.

Who can participate?
Adult men and women who have been using a catheter for ≥ 28 days and for whom there is no plan for discontinuation of catheter use at the time of recruitment, who are able to or has someone who can do catheter washouts for them.

What does the study involve?
Participants are randomly allocated to one of three groups for 24 months:
1. Weekly normal saline catheter washouts plus standard care
2. Weekly acidic (citric) catheter washouts plus standard care
3. Standard care only (i.e. no catheter washouts)
Participants are given a special calendar to record any problems with their catheter. They are contacted each month by a member of the research team who asks about any catheter-related problems they may have had. Every six months, participants are asked to complete a questionnaire about their quality of life and satisfaction with treatment.

What are the possible benefits and risks of participating?
Participants will receive the same level of care from their healthcare team whether or not they take part in the study. Participants may not benefit personally from taking part, but will be directly helping us to improve the care of patients with a long-term catheter in the future.
The washout solutions used in the study are already being used in the NHS. There may be a possible increase in the risk of urine infection when doing regular catheter washouts. The researchers will monitor this closely within the study and will ask participants about urine infections during every follow-up in the study. There are some side effects from the long-term use of catheters but the researchers do not think that the risk will be increased by introducing regular washouts.

Where is the study run from?
University of Aberdeen (UK)

When is the study starting and how long is it expected to run for?
October 2019 to September 2023

Who is funding the study?
National Institute for Health Research (NIHR) (UK)

Who is the main contact?
Dr Lynda Constable
l.constable@abdn.ac.uk

Study website

Contact information

Prof Mohamed Abdel-Fattah
Scientific

School of Medicine, Medical Sciences and Nutrition
University of Aberdeen
Second Floor
Aberdeen Maternity Hospital
Foresterhill
Aberdeen
AB25 2ZH
United Kingdom

Phone +44 (0)1224 438424
Email catheter2@abdn.ac.uk
Dr Lynda Constable
Scientific

Centre for Healthcare Randomised Trials (CHaRT)
3rd Floor
Health Sciences Building
University of Aberdeen
Foresterhill
Aberdeen
AB25 2ZD
United Kingdom

Phone +44 (0)1224 438144/8174
Email l.constable@abdn.ac.uk
Dr Diana Johnstone
Scientific

Centre for Healthcare Randomised Trials (CHaRT)
3rd Floor
Health Sciences Building
University of Aberdeen
Foresterhill
Aberdeen
AB25 2ZD
United Kingdom

Phone +44 (0)1224 438144/8174
Email diana.johnson@abdn.ac.uk

Study information

Study designRandomized; Both; Design type: Prevention, Device, Qualitative
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Community
Study typePrevention
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleRandomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter-associated complications in adults living with long-term catheters
Study acronymCATHETER II
Study hypothesisIn the UK, it is estimated that approximately 1 in 500 people live with a long term catheter. A urinary catheter is a thin, soft, flexible tube inserted into the bladder to drain urine to a collection bag. LTCs can be associated with complications including catheter blockage and urinary tract infections. Catheter blockages affect 50% of people with LTCs. Blockage and infection can impact upon quality of life and NHS resources.

There are two broad strategies for preventing and managing catheter blockage: more frequent change of catheter and/or the use of liquid solutions to washout or flush the catheters. We do not know enough about the benefits, harms or costs of regular prophylactic washouts, to recommend whether or not they should be standard care.

In this study the researchers will determine the clinical and cost-effectiveness, acceptability, satisfaction, and safety of weekly prophylactic catheter washout policies in addition to standard LTC care compared to standard LTC care only for adults living with LTC. The primary outcome is catheter blockage requiring intervention. The primary economic outcome is the incremental cost per quality adjusted life year (QALY) gained for each washout policy compared to standard LTC care only.
Ethics approval(s)Approved 22/03/2019, Wales REC6 (Health and Care Research Wales) (Wales National Pool, Sketty Lane, Swansea SA2 8QG; Tel: +44 (0)1267 611164, 01874 615949; Email: Wales.REC6@wales.nhs.uk), ref: 19/WA/0015
ConditionCatheter-associated complications
InterventionThe researchers are recruiting 600 people who have a LTC from primary care, secondary care and care homes. They are randomising participants to one of three groups:
1. Saline washouts. A policy of weekly prophylactic normal saline catheter washouts plus standard LTC care
2. Acidic washouts. A policy of weekly prophylactic acidic (citric) catheter washouts plus standard LTC care
3. Standard LTC care only (i.e. no prophylactic catheter washouts)

The researchers are following participants for 24 months to assess catheter blockages, infections, and complications, plus their quality of life, satisfaction, costs to the participant and NHS. They are exploring the views, attitudes, experiences and expectations of washouts with participants, nurses, and doctors.
Intervention typeProcedure/Surgery
Primary outcome measureAny catheter blockage requiring intervention up to 24 months post randomisation, from the question ‘Have you had any catheter blockages since we last spoke to you?’ from patient-reported monthly phone call CRF (monthly for 24 months) (Intervention is defined as any of the following: unplanned catheter removal or change or washout performed by the participant/ designated person or required unplanned visits to/from any healthcare provider, or hospital admission)
Secondary outcome measuresCurrent secondary outcome measures as of 22/04/2022:
1. S-CAUTI requiring antibiotics use from the questions ‘Have you had a urine infection since we last spoke to you?’ and ‘How many infections required antibiotics?’ from patient-reported monthly phone call CRF (monthly for 24 months)
2. Duration of LTC in situ, catheter change due to other reasons than blockage, discontinuation of LTC use; from the questions ‘Has there been discontinuation of long-term catheter use?’, ‘For the (reported problem), what treatment did you have?’ and Answers ‘Catheter change’ from patient-reported monthly phone call CRF (monthly for 24 months)
3. Adverse events; where participant has reported a treatment in the patient-reported monthly phone call CRF (monthly for 24 months) and the question of the clinical team is asked ‘Is this a SAE? Please tick’
4. Hospital admissions, GP/nurse outpatient visits for catheter-related complications from the questions ‘Since we last spoke to you, have you had to stay in hospital overnight for any of the problems related to your catheter?’, ‘For the (reported problem), where did you have treatment or a consultation with a doctor or nurse?’ and possible answers ‘GP at home, Nurse at home, care home staff, GP at surgery, Nurse at practice, Self/informal carer, Staff at hospital’ from patient-reported monthly phone call CRF (monthly for 24 months)
5. Generic quality of life assessed by EQ-5D-5L17 (EuroQol questionnaire – 5 dimensions – 5 levels) patient-reported questionnaire; Timepoint(s): 0, 6, 12, 18, 24 months post-randomisation
6. Condition-specific quality of life assessed by ICIQ-LTCqol18 (International Consultation on Incontinence Modular Questionnaire – Long Term Catheter quality of life) patient-reported questionnaire; Timepoint(s): 0, 6, 12, 18, 24 months post-randomisation
7. Adherence to allocated interventions,events changing type and/or frequency (or cessation) of catheter washouts in arms A and B and rates of commencing on prophylactic washouts in arm C; from the questions ‘Have you done a weekly washout since we last called you ?’, ‘Have you had any problems with the weekly washout?’, ‘Has your clinical care team recommended a change in washout frequency?’, ‘Has your clinical care team recommended a change in type of washout solution?’ and ‘Have you done any regular (preventative) washouts since we last called you?’ from patient-reported monthly phone call CRF (monthly for 24 months)
8. Patients’ convenience and satisfaction assessed by an adapted version of the abbreviated Treatment Satisfaction Questionnaire for medication; Timepoint(s): 0,6,12,18,24 months post-randomisation patient-reported questionnaire
9. Impact on day to day activities using the General Self-Efficacy Scale (GSE)20 and ICECAP-A (ICEpop CAPability measure for Adults) (≤ 65 years) or ICECAP-O21 (ICEpop CAPability measure for Older people) > 65 years patient-reported questionnaire; Timepoint(s): 0, 6, 12, 18, 24 months post-randomisation
10. Time and travel costs for patients and their relatives, friends or informal carers, from patient-reported questionnaire questions ‘We wish to know how much money and time were spent by you and any companion in attending health care appointments or being admitted to hospital’, including travel costs, time and whether or not accompanied by another person.; Timepoint(s): 18 months post-randomisation


Previous secondary outcome measures:
1. S-CAUTI requiring antibiotics use from the questions ‘Have you had a urine infection since we last spoke to you?’ and ‘How many infections required antibiotics?’ from patient-reported monthly phone call CRF (monthly for 24 months)
2. Duration of LTC in situ, catheter change due to other reasons than blockage; from the questions ‘Has there been discontinuation of long-term catheter use?’, ‘For the (reported problem), what treatment did you have?’ and Answers ‘Catheter change’ from patient-reported monthly phone call CRF (monthly for 24 months)
3. Adverse events; where participant has reported a treatment in the patient-reported monthly phone call CRF (monthly for 24 months) and the question of the clinical team is asked ‘Is this a SAE? Please tick’
4. Hospital admissions, GP/nurse outpatient visits for catheter-related complications from the questions ‘Since we last spoke to you, have you had to stay in hospital overnight for any of the problems related to your catheter?’, ‘For the (reported problem), where did you have treatment or a consultation with a doctor or nurse?’ and possible answers ‘GP at home, Nurse at home, care home staff, GP at surgery, Nurse at practice, Self/informal carer, Staff at hospital’ from patient-reported monthly phone call CRF (monthly for 24 months)
5. Generic quality of life assessed by EQ-5D-5L17 (EuroQol questionnaire – 5 dimensions – 5 levels) patient-reported questionnaire; Timepoint(s): 0, 6, 12, 18, 24 months post-randomisation
6. Condition-specific quality of life assessed by ICIQ-LTCqol18 (International Consultation on Incontinence Modular Questionnaire – Long Term Catheter quality of life) patient-reported questionnaire; Timepoint(s): 0, 6, 12, 18, 24 months post-randomisation
7. Adherence to allocated interventions; from the questions ‘Have you done a weekly washout since we last called you ?’, ‘Have you had any problems with the weekly washout?’, ‘Has your clinical care team recommended a change in washout frequency?’, ‘Has your clinical care team recommended a change in type of washout solution?’ and ‘Have you done any regular (preventative) washouts since we last called you?’ from patient-reported monthly phone call CRF (monthly for 24 months)
8. Patients’ convenience and satisfaction assessed by an adapted version of the abbreviated Treatment Satisfaction Questionnaire for medication; Timepoint(s): 0,6,12,18,24 months post-randomisation patient-reported questionnaire
9. Impact on day to day activities using the General Self-Efficacy Scale (GSE)20 and ICECAP-A (ICEpop CAPability measure for Adults) (≤ 65 years) or ICECAP-O21 (ICEpop CAPability measure for Older people) > 65 years patient-reported questionnaire; Timepoint(s): 0, 6, 12, 18, 24 months post-randomisation
10. Time and travel costs for patients and their relatives, friends or informal carers, from patient-reported questionnaire questions ‘We wish to know how much money and time were spent by you and any companion in attending health care appointments or being admitted to hospital’, including travel costs, time and whether or not accompanied by another person.; Timepoint(s): 18 months post-randomisation
Overall study start date01/10/2018
Overall study end date14/09/2023
Reason abandoned (if study stopped)Lack of funding/sponsorship

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 600; UK Sample Size: 600
Total final enrolment80
Participant inclusion criteria1. Aged ≥18 years
2. Catheter has been in-situ for ≥28 days
3. No plan for discontinuation of LTC at the time of recruitment
4. Able to undertake catheter washouts or has a designated person able to perform washouts
5. Able to complete the trial documentation or has a proxy able to complete the trial documentation
6. Any type and route of LTC can be included
Participant exclusion criteriaCurrent participant exclusion criteria as of 22/04/2022:
1. Intermittent self-catheterisation
2. Pregnant or contemplating pregnancy
3. Spinal cord injury at or above the sixth thoracic vertebra (T6) (risk of Autonomic Dysreflexia - AD)
4. Ongoing S-CAUTI (until treatment is complete)
5. Visible hematuria (unless investigated/ treated)
6. Known allergies to either of the catheter washout solutions
7. Current bladder cancer (until treatment is complete and patient discharged from cancer surveillance program)
8. Known bladder stones (until treatment is complete)
9. Unable to provide consent due to incapacity
10. Any other clinical and social reasons that would be deemed by the recruitment team to be unsuitable for the study

If a participant stops using a long-term catheter (no catheter in situ) >=28 days. All data collected up to the point of stopping long term catheter use are retained and used in the analysis


Previous participant exclusion criteria:
1. Intermittent self-catheterisation
2. Pregnant or contemplating pregnancy
3. Spinal cord injury at or above the sixth thoracic vertebra (T6) (risk of Autonomic Dysreflexia - AD)
4. Ongoing S-CAUTI (until treatment is complete)
5. Visible hematuria (unless investigated/ treated)
6. Known allergies to either of the catheter washout solutions
7. Current bladder cancer (until treatment is complete and patient discharged from cancer surveillance program)
8. Known bladder stones (until treatment is complete)
9. Any other clinical and social reasons that would be deemed by the recruitment team to be unsuitable for the study

If a participant stops using a long-term catheter (no catheter in situ) >=28 days. All data collected up to the point of stopping long term catheter use are retained and used in the analysis
Recruitment start date01/12/2019
Recruitment end date31/08/2022

Locations

Countries of recruitment

  • England
  • Scotland
  • United Kingdom
  • Wales

Study participating centres

NHS Grampian
Summerfield House
2 Eday Road
Aberdeen
AB15 6RE
United Kingdom
Northumbria Healthcare NHS Foundation Trust
Nursery Park
Nursery Road
Ashington
NE63 0HP
United Kingdom
West Rainton Surgery
Woodland View
West Rainton
Houghton-le-Spring
DH4 6RQ
United Kingdom
Great Lumley Surgery
Front Street
Great Lumley
Chester-le-Street
DH3 4LE
United Kingdom
The Haven Surgery
The Haven
Burnhope
DH7 0BB
United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Addenbrookes Hospital
Hills Road
Cambridge
CB2 0QQ
United Kingdom
The Chalgrove & Watlington Surgeries
Hill Road
Watlington
Oxford
OX49 5AF
United Kingdom
Aneurin Bevan University Health Board
Royal Gwent Hospital
Cardiff Road
Newport
NP20 2UB
United Kingdom
St Bartholomew's Medical Centre
Manzil Way
Cowley Road
Oxford
OX4 1XB
United Kingdom
Summertown Health Centre
160 Banbury Road
Oxford
OX2 7BS
United Kingdom
Priory Gardens Surgery
The Health Centre
Church St
Dunstable
LU6 3SU
United Kingdom
Gosford Hill Medical Centre
167 Oxford Road
Kidlington
Oxford
OX5 2NS
United Kingdom
Cwm Taf Morgannwg University Health Board
Royal Glamorgan Hospital
Ynysmaerdy
Llantrisant
CF72 8XR
United Kingdom
Derbyshire Community Health Services NHS Foundation Trust
Trust Hq, Ash Green Disability Ctr
Ashgate Road
Ashgate
Chesterfield
S42 7JE
United Kingdom
Bicester Health Centre
Coker Close
Bicester
OX6 7AT
United Kingdom
Ashgate Medical Practice
Ashgate Road
Chesterfield
S40 4AA
United Kingdom
Royal Primary Care Chesterfield
The Grange Family H/ctr
Stubbing Road
Grangewood
Chesterfield
S40 2HP
United Kingdom
Royal Primary Care Clay Cross
Eldon Street
Clay Cross
Chesterfield
S45 9NR
United Kingdom
Temple Sowerby Medical Practice
Linden Park
Temple Sowerby
Penrith
CA10 1RW
United Kingdom
Humber Teaching NHS Foundation Trust
Trust Hq, Willerby Hill
Beverley Road
Willerby
Hull
HU10 6ED
United Kingdom
Aspatria Medical Group
West Street
Aspatria
Wigton
CA7 3HH
United Kingdom
Leadgate Surgery
George Ewen House
Watling Street
Leadgate
Consett
DH8 6DP
United Kingdom
Vauxhall Health Centre
111-117 Limekiln Lane
Vauxhall
Liverpool
L5 8XR
United Kingdom
Swanage Medical Practice
Railway Station Approach
Swanage
BH19 1HB
United Kingdom
Chilwell Valley and Meadows Practice
Chilwell Meadows Surgery
Ranson Road
Chilwell
Nottingham
NG9 6DX
United Kingdom
Midlands Partnership NHS Foundation Trust
Trust Headquarters
St Georges Hospital
Corporation Street
Stafford
ST16 3SR
United Kingdom
St Francis Surgery
Pilgrims Close
Valley Park
Chandlers Ford
Southampton
SO53 4ST
United Kingdom
Hockley Farm Medical Practice
39 Hockley Farm Road
Braunstone
Leicester
LE3 1HN
United Kingdom
Wellbrook Medical Centre
Welland Road
Hilton
Derby
DE65 5GZ
United Kingdom
Banbury Cross Health Centre
South Bar House
6 Oxford Road
Banbury
OX16 9AD
United Kingdom
Pelton & Fellrose Medical Group
Unit 1, the Lavender Centre
Pelton Lane
Pelton
Chester Le Street
DH2 1HS
United Kingdom
The Shirley Health Partnership
Shirley Health Centre
Grove Road
Shirley
Southampton
SO15 3UA
United Kingdom
Highcliffe Medical Centre
Heila House
Lymington Road
Highcliffe
Christchurch
BH23 5ET
United Kingdom
East Lancashire Hospitals NHS Trust
Royal Blackburn Hospital
Haslingden Road
Blackburn
BB2 3HH
United Kingdom
Church Street Practice
The Health Centre
Mably Way
Grove
Wantage
OX12 9BN
United Kingdom
Derby Road Health
336 Derby Road
Nottingham
NG7 2DW
United Kingdom
King's College Hospital NHS Foundation Trust
Denmark Hill
London
SE5 9RS
United Kingdom
Manchester University Hospital NHS Ft (hq)
Oxford Road
Manchester
M13 9WL
United Kingdom
Solent NHS Trust
Solent NHS Trust Headquarters
Highpoint Venue
Bursledon Road
Southampton
SO19 8BR
United Kingdom
The White Horse Medical Practice
The Faringdon Medical Centre
Volunteer Way
Faringdon
SN7 7YU
United Kingdom
Mendip Vale Medical Practice (yatton)
155 Mendip Road
Yatton
Bristol
BS49 4ER
United Kingdom
Brierley Park Medical Centre
127 Sutton Road
Huthwaite
Sutton-in-ashfield
NG17 2NF
United Kingdom

Sponsor information

NHS Grampian
Hospital/treatment centre

-
-
AB15 6RE
Scotland
United Kingdom

ROR logo "ROR" https://ror.org/00ma0mg56

Funders

Funder type

Government

NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC); Grant Codes:

No information available

Results and Publications

Intention to publish date31/03/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe protocol will be publicly available on the study website and the NIHR HTA website. The researchers intend to publish the study protocol as soon as practicable.

Updated 08/08/2022:
The protocol has been published on 4th August 2022 and is available at https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-022-06577-2
IPD sharing planA request to access the datasets generated during the trial should be directed in the first instance to the corresponding author (Professor Mohamed Abdel-fattah, m.abdelfattah@abdn.ac.uk). The datasets collected in questionnaires at all timepoints and the baseline, monthly and serious adverse event case report forms for all 80 participants recruited to the trial are available. The dataset is available in fully anonymised electronic form, at an individual level, and in accordance with participant consent. The data dictionaries, study protocol, statistical analysis plan, patient information leaflets and template case report forms are also available on request to facilitate interpretation of data. Questionnaire templates, or parts thereof, may be available pending review of the relevant licensing agreements. Data for the study is currently available within a local repository at the University of Aberdeen and will be retained for a period of at least 10 years after close of trial in accordance with funder, Sponsor and local archiving procedures. Applicants will require to complete a data request form, which will be reviewed by a Data Sharing Committee which includes the Chief Investigator. Applications will be considered on a case-by-case basis from bonafide researchers. We are obligated to ensure that optimal use is made of the data that is collected for research and we recognise the value of sharing individual level data. The interests of research participants, researchers and other stakeholders will be considered when considering each application. A fully authorised data sharing agreement will be required prior to the release of data.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article 04/08/2022 05/08/2022 Yes No
HRA research summary 28/06/2023 No No
Results article 02/12/2024 03/12/2024 Yes No
Other publications Embedded longitudinal qualitative study 07/04/2025 08/04/2025 Yes No

Editorial Notes

08/04/2025: Publication reference added.
03/12/2024: Publication reference added.
25/10/2024: The participant level data sharing statement was added.
03/10/2024: The funder decided to stop the study early.
12/09/2024: The intention to publish date was changed from 31/03/2024 to 31/03/2025. IRAS number added.
11/10/2023: The following changes were made:
1. The overall study end date was changed from 29/02/2024 to 14/09/2023.
2. The total final enrolment was added.
08/08/2022: The following changes were made to the trial record:
1. The recruitment end date was changed from 31/03/2023 to 31/08/2022.
2. The overall trial end date was changed from 31/03/2023 to 29/02/2024.
3. Manchester University Hospital NHS Foundation Trust, Solent NHS Trust, The White Horse Medical Practice, Mendip Vale Medical Practice (yatton), and Brierley Park Medical Centre were added as trial participating centres.
05/08/2022: Publication reference added.
22/04/2022: The following changes have been made:
1. The recruitment end date has been changed from 30/04/2022 to 31/03/2023.
2. The secondary outcome measures have been updated.
3. The participant exclusion criteria has been updated.
4. The trial participating centres “Derbyshire Community Health Services NHS Foundation Trust”, “Bicester Health Centre”, “Ashgate Medical Practice”, “Royal Primary Care Chesterfield”, “Royal Primary Care Clay Cross”, “Temple Sowerby Medical Practice”, “Humber Teaching NHS Foundation Trust”, “Aspatria Medical Group”, “Leadgate Surgery”, “Vauxhall Health Centre”, “Swanage Medical Practice”, “Chilwell Valley and Meadows Practice”, “Midlands Partnership NHS Foundation Trust”, “St Francis Surgery”, “Hockley Farm Medical Practice”, “Wellbrook Medical Cente”, “Banbury Cross Health Centre”, “Pelton & Fellrose Medical Group”, “The Shirley Health Partnership”, “Highcliffe Medical Centre”, “East Lancashire Hospitals NHS Trust”, “Church Street Practice”, “Derby Road Health Centre”, and “King’s College Hospital NHS Foundation Trust” have been added.
10/01/2022: The recruitment end date was changed from 31/12/2021 to 30/04/2022.
26/05/2021: The following changes have been made:
1. The recruitment end date has been changed from 30/06/2021 to 31/12/2021.
2. The trial setting has been changed from Hospitals to Community.
3. The trial participating centres "Cambridge University Hospitals NHS Foundation Trust", "The Chalgrove & Watlington Surgeries", "Aneurin Bevan University Health Board", "St Bartholomew's Medical Centre", "Summertown Health Centre", "Priory Gardens Surgery", "Gosford Hill Medical Centre", and "Cwm Taf Morgannwg University Health Board" have been added.
04/09/2020: Recruitment to this study is no longer paused.
16/04/2020: Due to current public health guidance, recruitment for this study has been paused.
16/04/2020: NHS Lothian has been removed and Northumbria Healthcare NHS Foundation Trust, West Rainton Surgery, Great Lumley Surgery and The Haven Surgery have been added as trial participating centres.
04/11/2019: Trial's existence confirmed by the NIHR.